Brian Howard Eisner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Calculi | 49 | 2023 | 463 | 11.030 |
Why?
|
Ureteral Calculi | 28 | 2024 | 114 | 10.080 |
Why?
|
Ureteroscopy | 35 | 2024 | 146 | 7.700 |
Why?
|
Nephrolithiasis | 24 | 2024 | 116 | 7.550 |
Why?
|
Nephrostomy, Percutaneous | 16 | 2023 | 76 | 5.220 |
Why?
|
Ureter | 16 | 2023 | 367 | 4.550 |
Why?
|
Lithotripsy | 14 | 2023 | 140 | 4.390 |
Why?
|
Urolithiasis | 17 | 2023 | 125 | 4.090 |
Why?
|
Renal Colic | 6 | 2020 | 28 | 2.540 |
Why?
|
Lithotripsy, Laser | 8 | 2023 | 44 | 1.660 |
Why?
|
Urinary Tract Infections | 7 | 2024 | 802 | 1.610 |
Why?
|
Urinary Calculi | 9 | 2021 | 90 | 1.530 |
Why?
|
Ureteral Neoplasms | 7 | 2023 | 106 | 1.500 |
Why?
|
Ureteroscopes | 2 | 2022 | 22 | 1.490 |
Why?
|
Calcium Oxalate | 8 | 2023 | 75 | 1.480 |
Why?
|
Citric Acid | 6 | 2015 | 123 | 1.230 |
Why?
|
Ureteral Obstruction | 5 | 2017 | 293 | 1.090 |
Why?
|
Urology | 6 | 2024 | 400 | 1.040 |
Why?
|
Stents | 11 | 2023 | 3179 | 1.020 |
Why?
|
Sepsis | 7 | 2024 | 2585 | 1.020 |
Why?
|
Urine | 4 | 2012 | 362 | 1.020 |
Why?
|
Urologic Diseases | 2 | 2019 | 247 | 0.990 |
Why?
|
Hydronephrosis | 3 | 2016 | 271 | 0.950 |
Why?
|
Kidney Medulla | 3 | 2015 | 169 | 0.900 |
Why?
|
Kidney Pelvis | 4 | 2023 | 186 | 0.890 |
Why?
|
Cystinuria | 2 | 2020 | 19 | 0.860 |
Why?
|
Carcinoma, Transitional Cell | 6 | 2023 | 782 | 0.770 |
Why?
|
Thiazides | 2 | 2013 | 19 | 0.760 |
Why?
|
Calcium | 5 | 2015 | 5722 | 0.700 |
Why?
|
Potassium Citrate | 2 | 2018 | 8 | 0.690 |
Why?
|
Lasers, Solid-State | 5 | 2023 | 176 | 0.670 |
Why?
|
Decision Support Techniques | 5 | 2016 | 1998 | 0.660 |
Why?
|
Disposable Equipment | 1 | 2019 | 46 | 0.650 |
Why?
|
Shock, Septic | 2 | 2023 | 768 | 0.630 |
Why?
|
Retrospective Studies | 59 | 2024 | 80636 | 0.630 |
Why?
|
Tomography, X-Ray Computed | 24 | 2023 | 20570 | 0.610 |
Why?
|
Kidney Neoplasms | 11 | 2023 | 4249 | 0.590 |
Why?
|
Endoscopy | 5 | 2020 | 1851 | 0.590 |
Why?
|
Hydrodynamics | 1 | 2018 | 168 | 0.580 |
Why?
|
Humans | 157 | 2024 | 761504 | 0.560 |
Why?
|
Flank Pain | 1 | 2016 | 43 | 0.520 |
Why?
|
Calcium Phosphates | 2 | 2018 | 171 | 0.510 |
Why?
|
Hyperoxaluria | 2 | 2012 | 32 | 0.510 |
Why?
|
Antacids | 1 | 2015 | 94 | 0.500 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3808 | 0.500 |
Why?
|
Device Removal | 3 | 2021 | 630 | 0.500 |
Why?
|
Ureteral Diseases | 3 | 2013 | 63 | 0.480 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 588 | 0.470 |
Why?
|
Obesity, Morbid | 2 | 2016 | 1277 | 0.460 |
Why?
|
Dehydration | 1 | 2015 | 216 | 0.450 |
Why?
|
Male | 89 | 2024 | 360804 | 0.450 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2023 | 2223 | 0.440 |
Why?
|
Female | 91 | 2024 | 392644 | 0.440 |
Why?
|
Nutrition Surveys | 3 | 2019 | 1733 | 0.440 |
Why?
|
Citrates | 2 | 2011 | 134 | 0.430 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 3 | 2022 | 200 | 0.420 |
Why?
|
Circadian Rhythm | 4 | 2012 | 2576 | 0.410 |
Why?
|
Middle Aged | 64 | 2024 | 220895 | 0.410 |
Why?
|
Nomograms | 1 | 2014 | 230 | 0.410 |
Why?
|
Kidney Diseases | 4 | 2011 | 2091 | 0.410 |
Why?
|
Comprehension | 1 | 2018 | 621 | 0.410 |
Why?
|
Postoperative Care | 3 | 2015 | 1468 | 0.400 |
Why?
|
Carbonated Beverages | 2 | 2011 | 210 | 0.400 |
Why?
|
Prescription Drugs | 1 | 2019 | 631 | 0.390 |
Why?
|
Neutrophils | 1 | 2024 | 3767 | 0.390 |
Why?
|
Kidney Tubules | 1 | 2013 | 449 | 0.390 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2015 | 2243 | 0.380 |
Why?
|
Allopurinol | 1 | 2013 | 198 | 0.380 |
Why?
|
Sodium | 3 | 2015 | 1588 | 0.380 |
Why?
|
Vasectomy | 2 | 2017 | 51 | 0.370 |
Why?
|
Malates | 1 | 2010 | 34 | 0.350 |
Why?
|
Urinalysis | 6 | 2012 | 368 | 0.350 |
Why?
|
Alkalies | 1 | 2010 | 44 | 0.350 |
Why?
|
Obesity, Abdominal | 1 | 2013 | 374 | 0.350 |
Why?
|
Radiation Dosage | 7 | 2023 | 1958 | 0.350 |
Why?
|
Laparoscopy | 6 | 2013 | 2035 | 0.350 |
Why?
|
Body Mass Index | 3 | 2016 | 12953 | 0.350 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 7 | 2019 | 1222 | 0.340 |
Why?
|
Kidney Calices | 1 | 2009 | 26 | 0.340 |
Why?
|
Oxalates | 1 | 2010 | 98 | 0.340 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3205 | 0.340 |
Why?
|
Urogenital Neoplasms | 2 | 2009 | 131 | 0.340 |
Why?
|
Kidney | 7 | 2022 | 7048 | 0.340 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2009 | 163 | 0.340 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 236 | 0.340 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2010 | 91 | 0.340 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1670 | 0.340 |
Why?
|
Urologic Surgical Procedures | 4 | 2017 | 298 | 0.330 |
Why?
|
Chyle | 1 | 2009 | 19 | 0.330 |
Why?
|
Radiation Protection | 3 | 2013 | 424 | 0.330 |
Why?
|
Colic | 1 | 2009 | 44 | 0.330 |
Why?
|
Robotics | 3 | 2013 | 819 | 0.320 |
Why?
|
Treatment Outcome | 25 | 2023 | 64680 | 0.320 |
Why?
|
Magnesium | 1 | 2012 | 804 | 0.320 |
Why?
|
Ultrasonography | 4 | 2017 | 5972 | 0.320 |
Why?
|
Emergency Service, Hospital | 5 | 2023 | 7879 | 0.310 |
Why?
|
Adult | 52 | 2024 | 221177 | 0.300 |
Why?
|
Pain Measurement | 3 | 2016 | 3550 | 0.300 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2009 | 125 | 0.300 |
Why?
|
Fistula | 1 | 2009 | 212 | 0.290 |
Why?
|
Pressure | 2 | 2022 | 1154 | 0.290 |
Why?
|
Aged | 45 | 2024 | 169289 | 0.290 |
Why?
|
Foreign-Body Migration | 1 | 2009 | 219 | 0.280 |
Why?
|
Prostatectomy | 2 | 2013 | 1824 | 0.280 |
Why?
|
Mesenchymoma | 1 | 2006 | 49 | 0.270 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5440 | 0.260 |
Why?
|
Seasons | 1 | 2012 | 1520 | 0.260 |
Why?
|
Diet | 2 | 2015 | 8075 | 0.260 |
Why?
|
Swine | 4 | 2022 | 5915 | 0.260 |
Why?
|
Internet | 1 | 2018 | 3092 | 0.250 |
Why?
|
Beverages | 1 | 2011 | 821 | 0.250 |
Why?
|
Penile Neoplasms | 1 | 2006 | 161 | 0.250 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.240 |
Why?
|
Laser Therapy | 2 | 2023 | 1092 | 0.240 |
Why?
|
Risk Assessment | 8 | 2024 | 23995 | 0.230 |
Why?
|
Vas Deferens | 1 | 2004 | 54 | 0.230 |
Why?
|
Erythrocytes | 1 | 2013 | 2413 | 0.230 |
Why?
|
Oligospermia | 1 | 2004 | 59 | 0.230 |
Why?
|
Postoperative Complications | 7 | 2019 | 15631 | 0.230 |
Why?
|
Internship and Residency | 2 | 2024 | 5880 | 0.220 |
Why?
|
Vitamins | 1 | 2012 | 1635 | 0.220 |
Why?
|
Catheters, Indwelling | 1 | 2006 | 426 | 0.220 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 7407 | 0.220 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2176 | 0.220 |
Why?
|
Prevalence | 6 | 2023 | 15732 | 0.220 |
Why?
|
Sperm Count | 1 | 2004 | 229 | 0.220 |
Why?
|
Tulipa | 1 | 2022 | 1 | 0.220 |
Why?
|
Foreign Medical Graduates | 1 | 2024 | 77 | 0.210 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 973 | 0.210 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2023 | 2496 | 0.210 |
Why?
|
Eponyms | 1 | 2002 | 14 | 0.210 |
Why?
|
Recurrence | 6 | 2015 | 8465 | 0.210 |
Why?
|
Prosthesis Failure | 2 | 2021 | 1204 | 0.210 |
Why?
|
Oxidative Stress | 1 | 2013 | 3113 | 0.210 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 168 | 0.200 |
Why?
|
Lymphocyte Count | 1 | 2024 | 778 | 0.200 |
Why?
|
Embryology | 1 | 2002 | 30 | 0.200 |
Why?
|
Achievement | 1 | 2024 | 288 | 0.200 |
Why?
|
Mitomycin | 4 | 2023 | 263 | 0.200 |
Why?
|
Antibiotic Prophylaxis | 2 | 2018 | 636 | 0.200 |
Why?
|
Platelet Count | 1 | 2024 | 781 | 0.200 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2471 | 0.190 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3826 | 0.190 |
Why?
|
Uric Acid | 4 | 2023 | 807 | 0.190 |
Why?
|
Equipment Design | 4 | 2012 | 3510 | 0.190 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 247 | 0.190 |
Why?
|
Hypercalciuria | 2 | 2012 | 31 | 0.190 |
Why?
|
Leukocyte Count | 1 | 2024 | 1596 | 0.180 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 621 | 0.170 |
Why?
|
Cystine | 1 | 2020 | 94 | 0.170 |
Why?
|
Sex Characteristics | 1 | 2010 | 2639 | 0.170 |
Why?
|
Carcinoma, Renal Cell | 3 | 2010 | 3164 | 0.170 |
Why?
|
Multivariate Analysis | 5 | 2021 | 12059 | 0.160 |
Why?
|
Nephrology | 1 | 2002 | 263 | 0.160 |
Why?
|
Models, Statistical | 3 | 2013 | 5079 | 0.150 |
Why?
|
Factitious Disorders | 1 | 2018 | 39 | 0.150 |
Why?
|
Vitamin D | 1 | 2012 | 3303 | 0.150 |
Why?
|
Young Adult | 16 | 2021 | 59243 | 0.150 |
Why?
|
Risk Factors | 13 | 2021 | 74206 | 0.150 |
Why?
|
Prostatic Neoplasms | 3 | 2017 | 11118 | 0.150 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5840 | 0.140 |
Why?
|
Lymph Nodes | 1 | 2009 | 3466 | 0.140 |
Why?
|
Narcotics | 1 | 2019 | 336 | 0.140 |
Why?
|
Nanoparticles | 1 | 2009 | 1959 | 0.140 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3530 | 0.140 |
Why?
|
Urinary Tract | 1 | 2020 | 313 | 0.140 |
Why?
|
Consensus | 3 | 2022 | 3123 | 0.140 |
Why?
|
Lymphocytes | 1 | 2024 | 2612 | 0.140 |
Why?
|
Incidence | 8 | 2021 | 21353 | 0.140 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39106 | 0.140 |
Why?
|
Aged, 80 and over | 15 | 2021 | 58976 | 0.130 |
Why?
|
Body Size | 1 | 2019 | 463 | 0.130 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 699 | 0.120 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1096 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 973 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.120 |
Why?
|
Radiographic Image Enhancement | 2 | 2010 | 876 | 0.120 |
Why?
|
ROC Curve | 1 | 2023 | 3579 | 0.120 |
Why?
|
Holmium | 3 | 2023 | 29 | 0.120 |
Why?
|
Muscle Contraction | 1 | 2019 | 1201 | 0.120 |
Why?
|
Lasers | 2 | 2009 | 952 | 0.120 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5492 | 0.120 |
Why?
|
Kallikreins | 1 | 2015 | 220 | 0.120 |
Why?
|
Hypertension | 2 | 2015 | 8540 | 0.110 |
Why?
|
Intensive Care Units | 3 | 2023 | 3745 | 0.110 |
Why?
|
Urease | 1 | 2013 | 39 | 0.110 |
Why?
|
Self Report | 3 | 2021 | 3724 | 0.110 |
Why?
|
Urologic Neoplasms | 1 | 2016 | 314 | 0.100 |
Why?
|
Time Factors | 10 | 2021 | 39967 | 0.100 |
Why?
|
Ureterolithiasis | 1 | 2012 | 1 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15266 | 0.100 |
Why?
|
Sex Distribution | 2 | 2015 | 2281 | 0.100 |
Why?
|
Thulium | 2 | 2023 | 21 | 0.100 |
Why?
|
Urography | 2 | 2013 | 315 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2023 | 5294 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 36426 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2015 | 15842 | 0.100 |
Why?
|
Citrus sinensis | 1 | 2011 | 14 | 0.100 |
Why?
|
United States | 6 | 2023 | 72334 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 12974 | 0.100 |
Why?
|
Prospective Studies | 11 | 2023 | 54425 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1311 | 0.090 |
Why?
|
Benchmarking | 1 | 2018 | 1045 | 0.090 |
Why?
|
Linear Models | 2 | 2012 | 5871 | 0.090 |
Why?
|
Humidity | 1 | 2012 | 205 | 0.090 |
Why?
|
Prognosis | 5 | 2023 | 29625 | 0.090 |
Why?
|
Intestinal Absorption | 1 | 2012 | 400 | 0.090 |
Why?
|
Animals | 8 | 2022 | 168459 | 0.090 |
Why?
|
Nephrocalcinosis | 1 | 2011 | 52 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.090 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 2010 | 21 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1739 | 0.090 |
Why?
|
Postoperative Period | 3 | 2023 | 1813 | 0.090 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2651 | 0.090 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2010 | 42 | 0.090 |
Why?
|
Cohort Studies | 4 | 2024 | 41487 | 0.090 |
Why?
|
Nephrectomy | 3 | 2010 | 937 | 0.090 |
Why?
|
Supine Position | 2 | 2020 | 205 | 0.090 |
Why?
|
Diet Therapy | 1 | 2011 | 151 | 0.090 |
Why?
|
International Cooperation | 1 | 2016 | 1422 | 0.080 |
Why?
|
Myocardial Revascularization | 1 | 2013 | 790 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15500 | 0.080 |
Why?
|
Cystoscopy | 1 | 2009 | 131 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2010 | 2759 | 0.080 |
Why?
|
Health Personnel | 1 | 2023 | 3335 | 0.080 |
Why?
|
Calcium, Dietary | 1 | 2012 | 529 | 0.080 |
Why?
|
Sex Factors | 3 | 2018 | 10552 | 0.080 |
Why?
|
Quality of Life | 5 | 2023 | 13367 | 0.080 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 273 | 0.080 |
Why?
|
Ureterostomy | 1 | 2008 | 18 | 0.080 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.080 |
Why?
|
Probability | 2 | 2010 | 2477 | 0.070 |
Why?
|
Lymphatic Diseases | 1 | 2009 | 320 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 193 | 0.070 |
Why?
|
Standard of Care | 1 | 2011 | 551 | 0.070 |
Why?
|
Vascular System Injuries | 1 | 2011 | 246 | 0.070 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 518 | 0.070 |
Why?
|
Prostate-Specific Antigen | 2 | 2015 | 2469 | 0.070 |
Why?
|
Calcinosis | 1 | 2015 | 1469 | 0.070 |
Why?
|
Parathyroidectomy | 1 | 2009 | 242 | 0.070 |
Why?
|
Obesity | 3 | 2020 | 12947 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2927 | 0.070 |
Why?
|
Intraoperative Care | 2 | 2015 | 767 | 0.070 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2006 | 78 | 0.070 |
Why?
|
Adolescent | 10 | 2021 | 88319 | 0.070 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 396 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12148 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2010 | 2751 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2011 | 908 | 0.060 |
Why?
|
Age Factors | 3 | 2017 | 18395 | 0.060 |
Why?
|
Child | 7 | 2018 | 80153 | 0.060 |
Why?
|
Temperature | 1 | 2012 | 2226 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2009 | 947 | 0.060 |
Why?
|
Logistic Models | 3 | 2015 | 13255 | 0.060 |
Why?
|
Models, Anatomic | 1 | 2009 | 683 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2009 | 425 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5336 | 0.060 |
Why?
|
Gadolinium | 1 | 2010 | 960 | 0.060 |
Why?
|
Cryosurgery | 1 | 2010 | 474 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 769 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6770 | 0.060 |
Why?
|
Early Detection of Cancer | 2 | 2017 | 3201 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2396 | 0.060 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 462 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 785 | 0.060 |
Why?
|
Mitomycins | 1 | 2023 | 46 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1648 | 0.060 |
Why?
|
Carotid Stenosis | 1 | 2011 | 860 | 0.050 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1738 | 0.050 |
Why?
|
Social Class | 1 | 2012 | 2004 | 0.050 |
Why?
|
Pilot Projects | 3 | 2018 | 8631 | 0.050 |
Why?
|
Hospitalization | 1 | 2023 | 10723 | 0.050 |
Why?
|
Societies, Medical | 1 | 2015 | 3905 | 0.050 |
Why?
|
Therapeutic Irrigation | 1 | 2004 | 292 | 0.050 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1388 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9469 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3712 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 683 | 0.050 |
Why?
|
Urinary Retention | 1 | 2003 | 106 | 0.050 |
Why?
|
Nephrons | 1 | 2023 | 168 | 0.050 |
Why?
|
History, 18th Century | 1 | 2002 | 207 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 587 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2022 | 5247 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1940 | 0.050 |
Why?
|
Semen | 1 | 2004 | 347 | 0.050 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2022 | 173 | 0.050 |
Why?
|
Urothelium | 1 | 2022 | 269 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2021 | 504 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3245 | 0.040 |
Why?
|
Germany | 1 | 2002 | 875 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2047 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 940 | 0.040 |
Why?
|
History, 19th Century | 1 | 2002 | 720 | 0.040 |
Why?
|
Technology | 1 | 2022 | 292 | 0.040 |
Why?
|
Phantoms, Imaging | 2 | 2022 | 2526 | 0.040 |
Why?
|
Nifedipine | 1 | 2019 | 221 | 0.040 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2003 | 357 | 0.040 |
Why?
|
Prone Position | 1 | 2020 | 196 | 0.040 |
Why?
|
Boston | 2 | 2009 | 9326 | 0.040 |
Why?
|
Escherichia coli | 1 | 2011 | 4217 | 0.040 |
Why?
|
Disease Management | 1 | 2009 | 2508 | 0.040 |
Why?
|
Prostatic Hyperplasia | 1 | 2003 | 521 | 0.040 |
Why?
|
Coronary Disease | 1 | 2013 | 5914 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 846 | 0.040 |
Why?
|
Contrast Media | 3 | 2019 | 5311 | 0.040 |
Why?
|
Sus scrofa | 1 | 2019 | 428 | 0.040 |
Why?
|
Genital Neoplasms, Female | 1 | 2003 | 532 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2003 | 1784 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2005 | 1085 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3801 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 326 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1036 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14666 | 0.030 |
Why?
|
Smoking | 1 | 2013 | 9053 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4346 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2009 | 3415 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6343 | 0.030 |
Why?
|
Digital Rectal Examination | 1 | 2015 | 41 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20098 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11121 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2017 | 678 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2850 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2019 | 496 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3408 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1334 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3514 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18252 | 0.030 |
Why?
|
Child, Preschool | 4 | 2009 | 42230 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 7967 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 787 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2023 | 6484 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11460 | 0.030 |
Why?
|
Risk | 2 | 2015 | 9610 | 0.020 |
Why?
|
Outpatients | 1 | 2020 | 1597 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2013 | 198 | 0.020 |
Why?
|
Iopamidol | 1 | 2012 | 186 | 0.020 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1899 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2645 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2006 | 1626 | 0.020 |
Why?
|
Emergencies | 1 | 2017 | 1217 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2008 | 22176 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 29874 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3917 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9280 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7237 | 0.020 |
Why?
|
Subtraction Technique | 1 | 2012 | 512 | 0.020 |
Why?
|
Tensile Strength | 1 | 2010 | 330 | 0.020 |
Why?
|
Office Visits | 1 | 2013 | 595 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7390 | 0.020 |
Why?
|
Alloys | 1 | 2008 | 110 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2014 | 2115 | 0.020 |
Why?
|
Reoperation | 2 | 2008 | 4303 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10090 | 0.020 |
Why?
|
Osteoporotic Fractures | 1 | 2012 | 411 | 0.020 |
Why?
|
England | 1 | 2008 | 526 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3416 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3267 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 1972 | 0.020 |
Why?
|
Surgical Instruments | 1 | 2008 | 383 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2691 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2078 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 2254 | 0.020 |
Why?
|
Infant | 1 | 2006 | 36192 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18965 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1373 | 0.010 |
Why?
|
Catheterization | 1 | 2009 | 1428 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5671 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2880 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2008 | 1008 | 0.010 |
Why?
|
Libido | 1 | 2003 | 119 | 0.010 |
Why?
|
Intraoperative Period | 1 | 2003 | 510 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2696 | 0.010 |
Why?
|
Image Enhancement | 1 | 2012 | 2885 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5428 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6425 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2005 | 1834 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10209 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3688 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1418 | 0.010 |
Why?
|
Erectile Dysfunction | 1 | 2003 | 444 | 0.010 |
Why?
|
Software | 1 | 2012 | 4434 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21012 | 0.010 |
Why?
|
Mastectomy | 1 | 2005 | 1822 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14031 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14605 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2003 | 6228 | 0.010 |
Why?
|
Clinical Competence | 1 | 2010 | 4792 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11076 | 0.010 |
Why?
|
Physicians | 1 | 2010 | 4591 | 0.010 |
Why?
|